Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welcarb
Welcarb 450 mg is an intravenous chemotherapy injection containing Carboplatin, a platinum-based anti-cancer agent used to treat various malignancies, including ovarian cancer, lung cancer, and certain head and neck cancers. It works by inhibiting DNA replication, preventing cancer cell growth.
Uses of Welcarb
Treatment of advanced ovarian cancer.
Effective against non-small cell lung cancer (NSCLC).
Used in combination with other chemotherapies for head and neck cancers.
Recommended for other solid tumors as per oncologist guidance.
Benefits of Welcarb
Broad-spectrum anti-cancer activity.
Effective against platinum-sensitive tumors.
Well-tolerated with a predictable side effect profile.
Allows combination therapy for improved cancer management.
Mechanism of Action of Welcarb
Forms DNA cross-links, disrupting cancer cell replication.
Triggers programmed cell death (apoptosis) in tumor cells.
Prevents cancer cell division, slowing tumor progression.
Note: Welcarb should be administered under strict medical supervision. Regular blood tests are required to monitor kidney function and blood counts. Discuss potential side effects with your oncologist.